0 CHECKOUT

PRODUCT FILTERS

REGION

34
16
11
9
9

COUNTRY

6
3
3
1
1

CATEGORIES

  • 33
  • 11
  • 9
  • 7
  • 6
  • 6
  • 6
  • 6
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

65
71
71
131

PUBLISHED

12
14
32
131

PRODUCT TYPE

67
61
1
1
1

Search for: "Molecular Epidemiology of Chronic Diseases - DUPLICATE"

Molecular Epidemiology of Chronic Diseases

With the sequencing of the human genome and the mapping of millions of single nucleotide polymorphisms, epidemiology has moved into the molecular domain. Scientists can now use molecular markers to...

Published:  April 2008
Price: 

Animal Biotechnology - Technologies, Markets and Companies

This report describes and evaluates animal biotechnology and its application in veterinary medicine and pharmaceuticals as well as improvement in food production. Knowledge of animal genetics is important...

Published:  August 2016
Price:  From

Renal Disease Treatments: Products and Therapies

This report provides: - An in-depth analysis of the market for kidney failure treatment products and services, forecasting growth and trends in various sectors. - Analyses of market trends, with...

Published:  June 2016
Price:  From

Molecular Diagnostics - Technologies, Markets and Companies

This report describes and evaluates the molecular diagnostics technologies that will play an important role in practice of medicine, public health, pharmaceutical industry, forensics and biological...

Published:  August 2016
Price:  From

Biomarkers - Technologies, Markets and Companies

This report follows the broad definition of a biomarker as a characteristic that can be objectively measured and evaluated as an indicator of normal biological or pathogenic processes as well as pharmacological...

Published:  August 2016
Price:  From

Pain Therapeutics - Drugs, Markets and Companies

This report describes the latest concepts of pathomechanisms of pain as a basis for management and development of new pharmacotherapies for pain. Major segments of the pain market are arthritis, neuropathic...

Published:  August 2016
Price:  From

Alzheimer Disease - New Drugs, Markets and Companies

Alzheimer's disease remains a challenge in management. With nearly 8 million sufferers from this condition in the seven major markets of the world and anticipated increases in the future. Considerable...

Published:  August 2016
Price:  From

Antiviral Therapeutics - Technologies, Markets and Companies

This report reviews the current state-of-art of antiviral approaches including vaccines, pharmaceuticals and innovative technologies for delivery of therapeutics. The introduction starts with a practical...

Published:  August 2016
Price:  From

Early Vascular Aging (EVA)

Early Vascular Aging (EVA): New Directions in Cardiovascular Protection brings together the last decade of research related to the characterization of EVA, as well as the predictive power of pulse wave...

Published:  August 2015
Price: 

Frontier Pharma: Chronic Obstructive Pulmonary Disease (COPD) - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Chronic Obstructive Pulmonary Disease (COPD) - Identifying and Commercializing First-in-Class Innovation Summary Chronic Obstructive Pulmonary Disease (COPD) is a progressive...

Published:  December 2015
Price:  From

Personalized Medicine - Scientific and Commercial Aspects

The aim of personalized medicine or individualized treatment is to match the right drug to the right patient and, in some cases, even to design the appropriate treatment for a patient according to his/her...

Published:  August 2016
Price:  From

Parkinson’s Disease Therapeutics in Major Developed Markets to 2021: Early Pipeline Shifts Towards Disease-Modifying Therapies, while Short Term Growth Driven by Long-Acting Symptomatic Treatments

Parkinson's Disease (PD) is a progressive, chronic neurodegenerative condition, which is currently incurable. It is associated with old age, and characterized by the loss of neurons in the substantia...

Published:  February 2016
Price:  From

Global Immunology Market to 2022 - Large pipeline and competitive market to drive long-term market growth

Global Immunology Market to 2022 - Large pipeline and competitive market to drive long-term market growth Summary Immune-mediated inflammatory diseases are a very common set of chronic disorders...

Published:  December 2015
Price:  From

Frontier Pharma: Asthma - Identifying and Commercializing First-in-Class Innovation

Large and Innovative Pipeline: Analysis has confirmed the asthma pipeline to be highly active, with 252 products in active development across all stages. The range of mechanisms of action employed...

Published:  May 2015
Price:  From

Cardiovascular Drug Delivery - Technologies, Markets and Companies

Drug delivery to the cardiovascular system is different from delivery to other systems because of the anatomy and physiology of the vascular system; it supplies blood and nutrients to all organs of...

Published:  August 2016
Price:  From

Type 2 Diabetes Mellitus Therapeutics in Asia-Pacific Markets to 2021 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth

Diabetes mellitus is a group of metabolic diseases characterized by chronic hyperglycemia - high blood glucose levels - that results from defects in insulin secretion, insulin action, or a combination...

Published:  January 2016
Price:  From

COPD Therapeutics in Major Developed Markets to 2021: Emergence of Addition-in-Class and First-in-Class Products Offsets Sales Erosion of Leading Brands

Chronic Obstructive Pulmonary Disease (COPD) is a progressive disorder associated with chronic inflammation of the airways and lungs. Persistent breathing difficulties and repeated exacerbations of...

Published:  November 2015
Price:  From

Asthma Therapeutics in Asia-Pacific Markets to 2021 - High Prevalence and Launch of Late-Stage Biologics will Drive the Market in Spite of Affordability Concerns

Asthma Therapeutics in Asia-Pacific Markets to 2021 - High Prevalence and Launch of Late-Stage Biologics will Drive the Market in Spite of Affordability Concerns Summary Asthma is a common chronic...

Published:  March 2016
Price:  From

Hepatitis B Therapeutics in Major Developed Markets to 2021 - Increasing Number of Migrants from High-Prevalence Regions to Drive Market Growth

Hepatitis B is an infectious liver disease caused by the Hepatitis B Virus (HBV) and characterized by acute or chronic inflammation of the liver. Despite its status as a vaccine-preventable disease,...

Published:  March 2016
Price:  From

Gene Therapy - Technologies, Markets and Companies

Gene therapy can be broadly defined as the transfer of defined genetic material to specific target cells of a patient for the ultimate purpose of preventing or altering a particular disease state. Genes...

Published:  August 2016
Price:  From
Loading Indicator

Our Clients

  • NBC Universal Inc.
  • Samsung Electronics Co., Ltd.
  • E.ON SE
  • DHL International GmbH
  • University of Cambridge
  • Kone Oyj
  • BP Plc.